Marshall E Kadin Selected Research

Seroma

11/2021	Granzyme B Is a Biomarker for Suspicion of Malignant Seromas Around Breast Implants.
5/2021	IL-10, IL-13, Eotaxin and IL-10/IL-6 ratio distinguish breast implant-associated anaplastic large-cell lymphoma from all types of benign late seromas.
1/2020	Does Breast Implant-Associated ALCL Begin as a Lymphoproliferative Disorder?
1/2020	Cell of Origin and Immunologic Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma.
1/2020	Comparative Analysis of Cytokines of Tumor Cell Lines, Malignant and Benign Effusions Around Breast Implants.
1/2019	What Cytokines Can Tell Us About the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
1/2017	CD30+ T Cells in Late Seroma May Not Be Diagnostic of Breast Implant-Associated Anaplastic Large Cell Lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marshall E Kadin Research Topics

Disease

29	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 12/2022 - 07/2003
27	Neoplasms (Cancer) 12/2022 - 04/2002
18	Lymphoma (Lymphomas) 01/2020 - 05/2002
13	Hodgkin Disease (Hodgkin's Disease) 01/2017 - 04/2002
9	T-Cell Lymphoma (Lymphoma, T Cell) 11/2021 - 05/2002
8	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2021 - 05/2002
8	Mycosis Fungoides 01/2021 - 02/2003
8	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2021 - 02/2003
7	Seroma 11/2021 - 01/2017
4	Disease Progression 06/2016 - 05/2002
3	Psoriasis (Pustulosis Palmaris et Plantaris) 08/2021 - 11/2014
3	Lymphomatoid Papulosis 01/2020 - 08/2004
2	Hyperplasia 08/2021 - 03/2015
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 05/2021 - 04/2017
2	Eczema 01/2021 - 08/2014
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2020 - 02/2003
2	B-Cell Lymphoma (Lymphoma, B Cell) 12/2019 - 10/2004
2	Hypersensitivity (Allergy) 01/2018 - 08/2014
2	Leukemia 08/2014 - 01/2013
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2007 - 12/2006
1	Weight Loss (Weight Reduction) 08/2021
1	Fever (Fevers) 08/2021
1	Eosinophilia 01/2021
1	Asthma (Bronchial Asthma) 01/2021
1	Disease Susceptibility (Diathesis) 01/2021
1	Allergic Rhinitis 01/2021
1	Rhinosinusitis 01/2020
1	Carcinoma (Carcinomatosis) 04/2019
1	Ductal Carcinoma 04/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Plasmacytoma 01/2019
1	Inflammation (Inflammations) 01/2018
1	Seminoma 07/2017
1	Lymphedema (Milroy Disease) 07/2017

Drug/Important Bio-Agent (IBA)

15	CytokinesIBA 11/2021 - 01/2014
10	Anaplastic Lymphoma KinaseIBA 12/2020 - 04/2004
7	Biomarkers (Surrogate Marker)IBA 12/2022 - 04/2007
6	Interleukin-13IBA 08/2021 - 01/2018
6	Proteins (Proteins, Gene)FDA Link 08/2021 - 02/2003
5	AntigensIBA 12/2022 - 07/2003
5	Interleukin-6 (Interleukin 6)IBA 08/2021 - 03/2012
5	NF-kappa B (NF-kB)IBA 01/2011 - 04/2002
4	Interleukin-9 (Interleukin 9)IBA 12/2022 - 01/2019
4	Immunoglobulin E (IgE)IBA 01/2021 - 01/2014
4	LigandsIBA 01/2011 - 02/2003
3	Capsules (Microcapsules)IBA 12/2022 - 06/2016
3	ChemokinesIBA 08/2021 - 02/2003
3	Interleukin-10 (Interleukin 10)IBA 05/2021 - 01/2019
3	Transcription Factors (Transcription Factor)IBA 07/2016 - 11/2007
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2010 - 09/2003
3	fascinIBA 01/2010 - 05/2002
3	CD30 LigandIBA 04/2007 - 07/2003
2	Granzymes (Granzyme)IBA 12/2022 - 11/2021
2	EnzymesIBA 01/2020 - 01/2017
2	SuperantigensIBA 01/2020 - 12/2019
2	Cytokine Receptors (Cytokine Receptor)IBA 11/2017 - 01/2014
2	Chemokine ReceptorsIBA 09/2017 - 02/2003
2	Biological ProductsIBA 01/2017 - 09/2015
2	Pyridinolcarbamate (P23)IBA 04/2009 - 12/2006
2	6-sulfo sialyl Lewis XIBA 09/2008 - 04/2007
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 11/2007 - 08/2003
2	Oncogene Proteins (Oncogene Protein)IBA 11/2007 - 04/2004
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 04/2007 - 01/2007
2	NucleophosminIBA 09/2005 - 07/2003
1	Peptide Hydrolases (Proteases)FDA Link 11/2021
1	LipopolysaccharidesIBA 10/2021
1	Toll-Like Receptor 4IBA 10/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2021
1	Interleukin-8 (Interleukin 8)IBA 08/2021
1	Interleukin-17 (Interleukin 17)IBA 08/2021
1	Inflammation MediatorsIBA 05/2021
1	ChromatinIBA 01/2021
1	SiliconesIBA 12/2020
1	InterferonsIBA 01/2020
1	Interleukin-22 (IL-22)IBA 01/2020
1	AntibodiesIBA 12/2019
1	AllergensIBA 12/2019
1	Programmed Cell Death 1 ReceptorIBA 11/2019
1	Polycomb Repressive Complex 2IBA 01/2018
1	Histone MethyltransferasesIBA 01/2018
1	Histones (Histone)IBA 01/2018
1	Lysine (L-Lysine)FDA Link 01/2018
1	Enhancer of Zeste Homolog 2 ProteinIBA 01/2018
1	Janus KinasesIBA 11/2017
1	Janus Kinase InhibitorsIBA 11/2017
1	Chimeric Antigen ReceptorsIBA 09/2017
1	Retinoic Acid Receptor alphaIBA 04/2017
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 04/2017
1	RetinoidsIBA 04/2017
1	Member 7 Tumor Necrosis Factor Receptor SuperfamilyIBA 01/2017
1	KynurenineIBA 01/2017
1	JNK Mitogen-Activated Protein KinasesIBA 01/2017
1	Tryptophan (L-Tryptophan)FDA Link 01/2017

Therapy/Procedure

18	Breast Implants (Breast Implant) 12/2022 - 06/2016
10	Therapeutics 01/2018 - 09/2002
4	Drug Therapy (Chemotherapy) 09/2012 - 09/2002
3	Radiotherapy 09/2012 - 09/2002
1	Immunotherapy 11/2019
1	Orchiectomy (Orchidectomy) 07/2017
1	Lymph Node Excision (Lymph Node Dissection) 07/2017